Foreground Capital

Join our partner Alice Zheng for a virtual roundtable with Women's Health Access Matters alongside Jessica J. Federer, Oriana Papin-Zoghbi, and Alexandra Lundin! This conversation will explore actionable strategies to fast-track innovation, increase investment, and deliver significant economic and societal benefits in women's health. 📅 Date: Tuesday, December 3, 2024 ⏰ Time: 1:00-2:00 pm ET 🔗 Register now: https://lnkd.in/gXGn52XV CC: Carolee Lee, Lori Frank, Insight Partners, AOA Dx

Save the date for Tech4Eva - The global Femtech accelerator’s Conference on December 9th! Be part of shaping a brighter future for Women's Health! 👏 The 2024 hybrid Tech4Eva Conference is once again bringing together industry stakeholders from around the world, including corporates, investors, entrepreneurs, innovators, academic researchers, students, and ecosystem builders, to discuss the current and future of technologies for women’s health.   The year the conversation will focus on maternal health. 💪 More info on the start-ups showcased here: https://lnkd.in/dtbNpMs9 Register now: https://lnkd.in/ewJVV-xB

It's been a busy fall for Foreground Capital! 💫Boost by BioBreak: Elizabeth Bailey spoke on the panel “Women's Health: Advancing Innovation and Investment" alongside Luba Soskin, Global Clinical Lead at Bayer and Tatiana Yglesias Ulloa, Executive Director at Portal Innovations, LLC. The panel was moderated by Stephanie Oestreich, Managing Director at Multiple Myeloma Research Foundation - MMRF. 💫SF Tech Week: Alice Zheng spoke on the panel “The Future of Women's Health: Opportunities & Challenges” alongside Tara Viswanathan, CEO & Founder at Rupa Health, Laura Mason, Growth Investor at Composition Capital, Dorothy Kilroy (she/her), CCO at ŌURA and Sylvia Kang, Founder & CEO at Mira. The panel was moderated by Dasha Shunina, Venture Capital Contributor to Forbes, Founder of Women Tech Meetup, Ambassador Community & Partnerships at Puzzle. 💫 Harvard Business School Women's Health Summit: Elizabeth served as a judge at the Student Pitch Competition. Fellow judges included: Leslie Schrock, Author, investor, and entrepreneur, Eva Luo, OBGYN and Head of Clinical Solutions at Pomelo Care, and Thomas de Vlaam, Partner at Pillar VC. Congratulations to the winner Tess Kim, MD, founder of PeriPeach! 💫2024 Milken Institute Future of Health Summit: Elizabeth was invited to join the roundtable “A Collaborative Network to Advance Women's Health” to discuss the development of a national network and platform coalescing investors, researchers and stakeholders to foster and accelerate R&D, data-sharing, resource collection, and institutional knowledge exchange. She also had the chance to connect with Adaeze Enekwechi, CEO of our portfolio company Cayaba Care. 💫RAISE Global Summit We are proud to have been selected as one of the top 100 applicants out of 900 for the RAISE Global Summit. Stasia Obremskey participated in a roundtable with emerging managers and prospective LPs, discussing opportunities in women’s health investment. The summit offered a valuable chance to engage with limited partners interested in supporting emerging managers. Stasia also had the opportunity to connect with Paige Hendrix Buckner, CEO of All Raise.

Not every week where we have visitors from Europe 🌍 ! Thrilled to welcome Chandra P. Leo at HBM Partners AG and Artemis Women's Health Foundation and Siew-Veena Sahi, CEO + Co-Founder of our portfolio company,Testmate Health, to our neighborhood! CC: Alice Zheng Stasia Obremskey

What does the future of women's health look like post-election? As always, there are challenges and opportunities. Eva Epker spoke with our portfolio companies Cadence OTC and Evvy, along with Winx Health (formerly known as Stix), FLORA (Flora Fertility) and G2G - Innovative Government Affairs Consulting to get an inside scroop! CC: Samantha Miller 🌱 Liz Powell Laura J. McDonald Cynthia Plotch Laine Bruzek Dr. Christy Lane Jamie Norwood

Congratulations to the team at Evvy! "Evvy, known for its pioneering work in vaginal microbiome testing, today announced its expansion into treatments with a new line of prescription-grade products for vaginal symptom relief. The launch marks a significant milestone for the female-founded startup, as it’s the first time patients can access Evvy’s prescription products without first taking their vaginal microbiome test." Read the full scoop here: Priyanka Jain Laine Bruzek Pita Navarro

Important read by Anastassia Gliadkovskaya at Fierce Healthcare. We are proud to see our portfolio companies Cadence OTC and Nurx from Thirty Madison contributing to this conversation and recognized for the important work they are doing. "Last Wednesday, Cadence OTC, which makes its own morning-after pill, saw a 70% increase in web traffic and five times the weekly average amount of orders in one day. Since the election, it has donated $80,000 worth of products to universities in states with restricted reproductive health care, including Ohio, Iowa and Texas. Co-founder Samantha Miller 🌱 told Fierce Healthcare in a statement that she expects demand for an affordable morning-after pill to grow in the next four years. Cadence OTC also expects to grow its convenience store count next year and to continue donating its products, she added." "Female-focused virtual care company Nurx from Thirty Madison saw a 400% spike in daily patient requests for prescription Ella on Nov. 6 as well as a 600% increase in Plan B. This was the highest daily volume since Roe v. Wade was overturned. It also saw a 100% increase in birth control requests on the same day. “At Nurx, we see patients react to pivotal moments impacting reproductive care with increased interest in and purchases of emergency contraception and birth control,” Rajani Rao, senior vice president of Nurx, told Fierce Healthcare. “ Ft: Hey Jane Kiki Freedman Winx Health (formerly known as Stix) Wisp Monica Cepak, MBA Jamie Norwood,

Sending love, strength, and unbreakable resolve to the #womenshealth community today. While the headwinds may have gotten a bit stronger, it underscores just how vital our work is in this moment. Together, we will push forward—fighting for better quality care, accessible and equitable services, reproductive freedom, impactful research, and innovations that truly meet the needs of women everywhere. To the incredible entrepreneurs and #VCs committed to advancing the health and well-being of women: this is just the beginning. Know that we are in this together and we will persevere. ❤️ Stasia Obremskey Alice Zheng Tricia Kostichka Ariel Kramer Foreground Capital Maria D. Toler, Casey Albert, Linda Greub, CFA, MBA Tracy Dooley MD Annie Theriault, Megan Dover, P.Eng., MBA, Donna Parr, Carli Sapir, Arianne Kidder, Colleen Foster, Jessica Karr, Maneesha Ghiya, AOA Dx, Bloomlife Inc, Cadence OTC, Cofertility, Contraline, Cirqle Biomedical , Cayaba Care, Eli Health, Mae, Millie, Novocuff, Inc., OCON Therapeutics, Fluus, Seven Starling, Raydiant Oximetry, Inc., Testmate Health, Twentyeight Health, YourChoice Therapeutics, Vitra Labs, Nurx from Thirty Madison

Thank you Dasha Shunina for highlighting Foreground Capital in your latest Forbes article on investing in women's health! "Some funds focus specifically on women’s health, like Foreground Capital. The founding team of Elizabeth Bailey, Stasia Obremskey and Alice Zheng is building on its track record and continued management of RH Capital’s Fund I & II to bring a new level of innovation, equity and impact to the sector." "Foreground Capital seeks companies that drive significant changes in care standards or make healthcare more accessible, especially for underserved communities. In its previous fund, Foreground Capital focused on female-specific conditions. Now, they’re expanding to invest in areas affecting women differently and disproportionately. Alice Zheng explains, “Women’s health is broad. Some issues need new science, so we’re looking at innovations in diagnostics, therapeutics, and devices. Other challenges involve access to care, so we’re exploring telehealth and even consumer health solutions.” CC: Sylvia Kang Mira Laura Mason Composition Capital Tara Viswanathan Rupa Health Dorothy Kilroy (she/her) ŌURA

Congratulations to our portfolio companies Raydiant Oximetry, Inc. and Bloomlife Inc! The The National Institutes of Health recently announced the winners of the RADx® Tech Fetal Monitoring Challenge! This $2M prize competition aims to fast-track life-saving diagnostic and monitoring technologies for fetal health, especially for use in low-resource settings worldwide. 🌎 Read more here: https://lnkd.in/e3sUMiFq CC: Neil Ray Eric Dy